Literature DB >> 14577808

Orthopedically induced condylar growth in a patient with hemifacial microsomia.

S Sidiropoulou1, K Antoniades, G Kolokithas.   

Abstract

OBJECTIVE: Hemifacial microsomia is a congenital abnormality that causes three-dimensional facial asymmetry, affection of the dental occlusion, and failure of growth of the midface in the growing child. This report outlines orthopedically induced condylar growth in a patient with hemifacial microsomia. PATIENT: A 7-year-old girl with hemifacial microsomia, complete absence of the left mandibular condyle, and severe facial asymmetry was treated orthopedically in an early stage by means of a functional appliance. Functional therapy was instituted to stretch the deficient soft tissues to guide and promote skeletal growth and stimulate the affected areas. The treatment was completed with fixed appliances.
RESULTS: The effect of the therapy was an excessive change in condylar growth in the affected side. Facial asymmetry was corrected and a symmetric mouth opening was established.
CONCLUSIONS: The treatment of patients with hemifacial microsomia should be initiated early enough so that the stimulus could in some degree normalize the deficient tissues and induce bone apposition, and in some cases surgical intervention could be avoided.

Entities:  

Mesh:

Year:  2003        PMID: 14577808     DOI: 10.1597/1545-1569_2003_040_0645_oicgia_2.0.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  2 in total

1.  Aneurysmal bone cyst located in the mandibular condyle.

Authors:  Sandro Pelo; Giulio Gasparini; Roberto Boniello; Alessandro Moro; Pier Francesco Amoroso
Journal:  Head Face Med       Date:  2009-02-16       Impact factor: 2.151

2.  Temporomandibular Joint Dysplasia in Cranio-Maxillofacial Dysplasia: A Retrospective Study. Guideline Treatment Proposal.

Authors:  Joël Ferri; Matthias Schlund; Sandrine Touzet-Roumazeille; James J Sciote; Romain Nicot
Journal:  J Craniofac Surg       Date:  2021-05-01       Impact factor: 1.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.